Bruker Corporation has emerged as the winner of an auction for NanoString Technologies and its spatial biology assets after the company filed for Chapter 11 bankruptcy earlier this year. The ...

Bruker (NASDAQ:BRKR) will buy NanoString Technologies, a Seattle-based innovator in gene expression profiling and spatial transcriptomics for ~$392.6M in cash, and the assumption of certain ...

More than a month after filing for Chapter 11 bankruptcy, NanoString Technologies has agreed to be acquired by the healthcare investment firm Patient Square Capital for $220 million pending approval ...

NanoString, which has been acquired by Bruker, has won a victory in a patent battle with 10x Genomics. Billerica, MA-based Bruker said that the German Federal Patent Court has ruled in favor of ...

This week, the GEN editors discuss business news from NanoString, Curio, and Cellares. Featuring Alex Philippidis (Senior Business Editor), Uduak Thomas (Senior Editor), Jonathan Grinstein, PhD, ...

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced that ...

NanoString Technologies (OTC:NSTGQ) has signed an agreement with Patient Square Capital, a leading healthcare investment firm, to acquire the majority of NanoString’s global business assets for a sum ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The acquisition marks the close ...

“Our work focuses on understanding how and why the risk of neurodegenerative diseases increases with advanced age. We discovered that senescent cells, which accumulate with aging, contribute to brain ...

This is a summary of a request from NanoString Technologies to hire Weil Gotshal & Manges as special patent counsel, filed Feb. 26 with the U.S. Bankruptcy Court in Delaware.